When preparing for monitors' visits, what should the CRC do?

When preparing for monitors' visits, what should the CRC do?

• A. Schedule patient visits only.
• B. Write the final study report.
• C. Stop data collection until monitoring is complete.
• D. Prepare for visits, respond to findings, resolve queries.

Answer: (D)

Preparing for monitors' visits means being audit-ready and actively managing the review process. The CRC ensures all essential documents are organized and up to date, that source data and case report forms are reconciled, and that the trial site operates in compliance with the protocol and regulatory requirements. In the lead-up to and during the visit, the CRC gathers the necessary materials, provides access to files, and tracks open queries. When monitors identify issues, the CRC responds promptly with requested information and implements corrective actions to resolve those queries. This combination of proactive preparation, clear documentation, and timely issue resolution supports data integrity and regulatory compliance throughout the trial. Scheduling patient visits only would leave regulatory documents and data quality checks incomplete. Stopping data collection during monitoring is not appropriate and can disrupt the trial’s ongoing conduct. Writing the final study report is a post-trial activity, not part of the visit preparation.

Preparing for monitors' visits means being audit-ready and actively managing the review process. The CRC ensures all essential documents are organized and up to date, that source data and case report forms are reconciled, and that the trial site operates in compliance with the protocol and regulatory requirements. In the lead-up to and during the visit, the CRC gathers the necessary materials, provides access to files, and tracks open queries. When monitors identify issues, the CRC responds promptly with requested information and implements corrective actions to resolve those queries. This combination of proactive preparation, clear documentation, and timely issue resolution supports data integrity and regulatory compliance throughout the trial.

Scheduling patient visits only would leave regulatory documents and data quality checks incomplete. Stopping data collection during monitoring is not appropriate and can disrupt the trial’s ongoing conduct. Writing the final study report is a post-trial activity, not part of the visit preparation.